Navigating Drug Shortages and Alternative Therapies

Judith Hey-Hadavi, vice president of Medical Affairs at Worldwide Clinical Trials, and Nicole Snow, senior clinical pharmacy liaison at Olympia Pharmaceuticals, discuss the challenges of GLP-1 receptor agonist drug shortages and the role of compounded alternatives in patient care. They highlight safety concerns with compounded medications, including variable dosing, lack of standardized delivery devices, and the risk of counterfeit products. Both emphasize the importance of patient education, proper administration training, and monitoring supply chains to ensure safety and efficacy.